Ottawa, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The global clinical trial packaging market size is predicted to increase from USD 3.62 billion in 2025 to approximately USD 9.12 billion by 2034, according to a study published by Towards Packaging a sister firm of Precedence Statistics. The industry is representing a double-digit CAGR of 10.80% between 2024 and 2034. The North America region accounted for the largest market share of 52% in 2023. The Asia Pacific region is expected to expand at the fastest CAGR during the forecast period.
Download Statistical Data: https://www.towardspackaging.com/download-statistics/5247
Key Takeaways: Leading Factors of the Clinical Trial Packaging Market
- Easy convenience and use of packaging by patients is the major factor that drives the market.
- Increase in number of drug trails perceives growth in North America due to availability of established research institutions.
- Clinical research organisation segment is the dominating sector in market due to efficiency in clinical trials.
- Ensuring compliance with strict regulations is an unceasing challenge for the market.
Market Overview
The clinical trial packaging market revolves around the efficient manufacturing and development of special packaging solutions which are used in trails for investigating products. Along with this, product integrity, chemical resistance and safety are the leading objectives of the market. The ability to open the packaging with ease has increased the demand of the market.
The product investigation uses attributes to the patient safety and stability of the packaging procedure. The efficiency in packaging material is excellent since it hardly reacts with its content and its ability to avoid contamination and loss pf potency has been a major factor for the growth of the market. Its label features also provide consumers product content information.
Get the latest insights on packaging industry segmentation with our Annual Membership: https://www.towardspackaging.com/get-an-annual-membership
Driver
Requirement in pharmaceutical sector and AI Integration
The major driving factor is the increasing demand for efficient and safe containers which will provide high resistance and degradation of the drugs has increased the demand of clinical trials packaging market. The advancements in clinical trials and development in new therapies has also driven the market growth. The drug container interaction, patient safety and innovative solution for chid resistance closures have increased the demand of the market in pharmaceutical sector. The easier and safe openings can attract consumers and tamper evident seals can avoid contamination of medical products.
The integration of labelling technology can provide high quality visible information and with trending technologies like blistering, bottling, pouching and over-encapsulation, it can do so with high precision. The temperature monitoring device and insulated shipper will provide product excellent stability. The integration of different labelling solutions like multi-panel, multi-language clinical labelling and serialisation can provide many opportunities for the market. child-resistant packs technology can significantly improve product security. Integration of patient-centric kits will also contribute to the market growth.
If there's anything you'd like to ask, feel free to get in touch with us @ sales@towardspackaging.com
Restraint
Production costs and strict regulations hinder the market growth
The leading challenges which hinder the growth of clinical trial packaging market is production costs and government regulations. The prices of production affect the market growth due to the advanced techniques used for the manufacturing packaging.
The government regulations with its complex regulation nature and specific standards can increase the costs of the packaging and can also hinder the growth of the market. Apart from this, changes in regulations due to external factors can affect the key players and can compile them to adopt packaging solutions. Pharmaceuticals companies will reduce investments in clinical trails due to ethical issue and due to high packaging costs.
Opportunity
Increase in clinical investments and emerging markets creates opportunities
The clinical trial packaging market offers opportunities in pharmaceutical industry due to excellent resistance against external factors and prevents contamination of medical products. The demand for clinical trials packaging is also due to the increasing consumer preferences which are convenience, patient safety and easy opening. The integration digital technology and investments in research and development for clinical trials also creates opportunities. Offering customized packaging to consumers can also create new pathways for the market.
Regional Insights
North America is the dominating clinical trial packaging market and has the largest share due to its highly developed infrastructure which runs logistics smoothly and also has a strong supply chain network. Clinical trials in America are an essential part which provide, create a deliver effective health care solutions and will improve healthcare outcomes which in return will drive the clinical trial packaging market.
The stringent regulations by regulators boards like the U.S. Food and Drug Administration (FDA) and Health Canada ensure that clinical trials follow protocols regarding safety features, labelling of packed product and tracking its destination. Although one factor that pushes back the market is high costs for clinical trials due to government regulations and labour costs.
In June 2024, Verona Pharma has released a statement, in which it has stated its preparations for upcoming launch of ensifentrine in US market and its pending approval from FDA which the company has expected to receive by end of June 2024.
Europe is a significant and matured marketplace and is a preferred choice for clinical trials due to their established healthcare infrastructure and also due to their diverse supply chain. The focus and safety and quality packaging increase the market growth. The market is driven by ageing population and the increased medical spending consequently skyrockets the packaging demand for clinical trials.
The high quality of cost production and inspection processes are the driving factors of the market. Multinational clinical research and infrastructure network are held highly important sections in European manufacturing processes which come under regulatory standards. The increase in chronic diseases also increases the requirement of drug trials which can improve healthcare issues.
In September 2024, PCI Pharma Services, (“PCI”) a global contract development and manufacturing organisation (CDMO) had invested more than $365 million to support the clinical and commercial-scale final assembly and also advanced drug delivery systems.
Asia-Pacific is the fastest growing region in the clinical trial packaging market due to the increasing population rate and their economic spending. The major factors driving Asia-Pacific market are the increased medical spending, increased investments in research and development and the regulatory standards for the clinical trials. The traditional packaging of products is preferred choice of customers and the top-notch component which increases the packaging demand is that customers can easily access the product during utilization. Its tamper-proof ability increases market demand, given the reason it is a preferred option for pharmaceuticals companies. Countries like China and India are the leading contributors in the market and India’s medical tourism has also increased the market rate.
In October 2023, Lokavant had been able to collect funding of $8 million in a Series A extension round and it was from global investment company Mitsui. The purpose behind the fuunding was to expand AI clinical trial intelligence platform across the Asia-Pacific (APAC) region.
Clinical Trial Packaging Market Top Companies
- Bilcare
- Fisher Clinical Services
- WuXi AppTec
- PCI Pharma Services
- Almac Group
- PharMaterials
- PAREXEL
- Schreiner MediPharm
- Sharp Packaging
- The Coghlan Group
- Rubicon
- Westrock
- Xerimis
- Catalent
- Piramal Pharma Solutions
- Corden Pharma
- DMB Consultancy
- Körber Medipak Systems
- Sentry BioPharma
- NextPharma
- Mawdsleys
Recent Development
| Company | BAP Pharma |
| Headquarters | USA |
| Recent Development | In May 2024, BAP Pharma had hosted a grand opening ceremony for its US headquarters and Founder and Managing Director of BAP Pharma, Dr. Bashir Parkar stated that the company will continue to provide clinical trial solutions for its customers. |
| Company | Iovance |
| Headquarters | USA |
| Recent Development | In February 2024, Iovance had received approval of TIL cell therapy and had been the first company to sell cellular medicine built from tumor-infiltrating lymphocytes in market. |
Segments Outlook
By Material Type Outlook
The plastic segment is the dominating segment in the clinical trial packaging market. It is dominating due to its properties which are enhanced protection and flexibility. The plastic segment can eliminate the single-use packaging approach and can also offer environmental benefit due to its reusable features. All these qualities ensure high quality packaging of medical substances and this increases their demand in the market.
The glass segment is the fastest growing segment in clinical trial packaging market. It is dominating due to its properties which are product integrity and safety. The glass segment with ability of transportation and maintaining the product’s safety ensures the need of durable packaging. Consumers prefer glass containers due to its sealing ability and lightweight bodies which are easily breakable and are mostly need in pharmaceutical industries.
By End-User Industry Outlook
The clinical research organization segment is the dominating segment in the clinical trial packaging market. The segment dominates due to increasing requirement for investigating medical products. The segment helps to design protocols for the trials and they provide high brief rules about labelling the product and altering consumers about child-resistance features.
The major factor which drives the clinical trial packaging in pharmaceutical sector is due to its product protocols and supply chain management. In pharmaceutical segment, safety of patients is most important and CROs prioritize them. They also have permission to collect data of patients for research and purposes and they also analyse packaging performance as well.
More Insights in Towards Packaging
- The global aluminum tubes market size reached US$ 850 million in 2023 and is projected to hit around US$ 1,564.03 million by 2034, expanding at a CAGR of 5.7% during the forecast period from 2024 to 2034.
- The global active packaging market size is estimated to grow from USD 19.2 billion in 2022 at 7.5% CAGR to reach an estimated USD 39.51 billion by 2032, between 2023 and 2032.
- The global antimicrobial packaging market size was at USD 10.77 billion in 2022 to hit around USD 18.81 billion by 2032, at 5.7% CAGR between 2023 to 2032.
- The global automotive packaging market size is estimated to grow from USD 8.18 billion in 2022 to reach an estimated USD 13.87 billion by 2032, at 5.4 % CAGR between 2023 and 2032.
- The global frozen food packaging market size is predicted to grow from USD 43.36 billion in 2022 to reach USD 71.67 billion by 2032, at 5.2% CAGR from 2023 to 2032.
- The global flexible packaging market size is estimated to grow from USD 283 billion in 2022 to reach an expected USD 445.82 billion by 2032, at 4.7% CAGR during the forecast period 2023 to 2032.
- The global food packaging market size was valued at USD 356.5 billion in 2022 and is expected to reach USD 659.80 Billion by 2032 and is poised to grow at a CAGR of 6.4% during the forecast period 2023 to 2032.
- The global smart packaging market size was estimated at USD 36.04 billion in 2022 to set a foot on USD 68.99 billion by 2032 with a registered CAGR of 6.8% from 2023 to 2032.
- The global plastic packaging market size reached USD 381.57 billion in 2022 and is projected to hit around USD 584.09 billion by 2032, growing at a CAGR of 4.4% from 2023 to 2032.
- The global intelligent packaging market size accounted for USD 24.23 billion in the year 2023 and it is predicted to hit around USD 54.38 billion by 2032, registering at a CAGR of 9.4% from 2023 to 2032.
Clinical Trial Packaging Market Segment
By Clinical Trial Type
- Therapeutic and Prevention
- Vaccines
- Drug Discovery and Development
- Therapeutic Devices
- Biosimilars
- Therapeutic Assays
- Therapeutic Procedures
- Diagnostics
- Diagnostic Assay
- Diagnostic Devices
By Packaging Type
- Bags & Pouches
- Syringes
- Vials & Ampoules
- Blisters
- Cold Forming
- Thermoforming
- Tubes
- Bottles
- Sachets
- Kits or Packs
- Others
By Material
- Plastic
- PVC
- PE
- HDPE
- LDPE
- PP
- Others
- Glass
- Metal
- Paper
- Corrugated Fiber
By End User
- Clinical Research Organizations
- Research Laboratories
- Drug Manufacturing Facilities
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait
View Clinical Trial Packaging Market Full TOC: https://www.towardspackaging.com/table-of-content/clinical-trial-packaging-market-sizing
Buy Premium Global Insight @ https://www.towardspackaging.com/price/5247
If you have any questions, please feel free to contact us at sales@towardspackaging.com
About Us
Towards Packaging is a leading global consulting firm specializing in providing comprehensive and strategic research solutions. With a highly skilled and experienced consultant team, we offer a wide range of services designed to empower businesses with valuable insights and actionable recommendations. We stay abreast of the latest industry trends and emerging markets to provide our clients with an unrivalled understanding of their respective sectors. We adhere to rigorous research methodologies, combining primary and secondary research to ensure accuracy and reliability. Our data-driven approach and advanced analytics enable us to unearth actionable insights and make informed recommendations. We are committed to delivering excellence in all our endeavours. Our dedication to quality and continuous improvement has earned us the trust and loyalty of clients worldwide.
Browse our Brand-New Journal:
https://www.towardshealthcare.com/
https://www.precedenceresearch.com/
https://www.towardsdental.com/
For Latest Update Follow Us: https://www.linkedin.com/company/towards-packaging/
